Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
Beijing Hotgen Biotech Co. Ltd. has issued an announcement regarding abnormal fluctuations in its stock trading. The company's stock price experienced significant increases over three consecutive trading days, exceeding a specified threshold. The board confirmed that there are no undisclosed significant matters affecting the stock's trading price. The company also warned investors about potential risks related to profit losses and ongoing drug development challenges.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/beijing-hotgen-biotech-co-ltdannouncement-on-abnormal-fluctuations-in-stock-trading
Beijing Hotgen Biotech Co. Ltd. on 6ix
Earlier from Beijing Hotgen Biotech
- Announcement on Progress in Repurchasing Shares
- Announcement on Voluntary Disclosure of Obtaining the "Drug Clinical Trial Approval Notice" for Subsidiary’s Innovative Drug SGT003 Injection
- Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Restrictions Concerning Share Repurchase
- Announcement on Initial Share Repurchase by the Company via Call Auction
- Announcement on Early Termination of the Repurchased Shares Sale Plan and the Results of the Sale of Repurchased Shares
Later from Beijing Hotgen Biotech
- Announcement on Voluntary Disclosure of Obtaining "Drug Clinical Trial Approval" for New Indication of Subsidiary's Innovative Drug SGC001 Injection
- Announcement on Adjustment of Core Technical Personnel
- Announcement on Implementation Results of Share Repurchase and Share Changes
- Announcement on Change of Registered Capital, Amendment to the Articles of Association and Filing of Industrial and Commercial Registration Changes
- Announcement on Voluntary Disclosure of Completion of First Subject Enrollment and Dosing in the Phase I/IIa Clinical Trial of Subsidiary's Innovative Drug SGT003
Follow Beijing Hotgen Biotech into a list and get an email when it puts out news.
Follow Beijing Hotgen Biotech